Thanks Jase,
"But we will be working with them and indeed the others during April/May and beyond and the first course is to work out what markets we can discuss that they will each be looking at attacking. And what products they may wish to take (hot dots, mineralisation, kneeguard, tendons) etc. It is very complex set of market sectors and products we can offer with our Lubricen, alternative OBJ formulations or with our partners' own formulations. "
It sounds like there is no doubt that at the moment there will be at least 2 and possibly more companies looking at 1 or more applications each, whether with Lubrican or their own formulation. Interesting to mention 'tendons' as well because that in itself applies to wherever a muscle attaches to bone - usually either end. That gives a large scope for so many different areas to be treated. It seems like P&G may get 1st slice of the pie but the other companies may make sure there are only a few crumbs left, hopefully a great example of co-optition at work.
SK75
- Forums
- ASX - By Stock
- 24th March - P&G Execution Date on BG
Thanks Jase, "But we will be working with them and indeed the...
-
-
- There are more pages in this discussion • 218 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WFL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, MD & CEO
Charles Armstrong
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online